Mammoth Biosciences
Karina Kono has worked as a Senior Research Associate at Mammoth Biosciences since April 2022. Prior to that, Karina held a similar role at System Biosciences from February 2021 to April 2022. Before entering the biotech industry, Karina gained experience as a Research Associate II and Laboratory Technician at Trace Genomics and as a Research Assistant II at Salk Institute for Biological Studies. Karina also worked as a Tutor at Kumon North America, Inc. Karina holds a Master of Science in Biology from UC San Diego and a Bachelor's degree in Biochemistry and Cell Biology from the same institution, as well as completing coursework at Foothill College.
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.